论文部分内容阅读
肝纤维化是慢性肝病、肝硬化的病理特征之一 ,这种病理改变贯穿于慢性肝病发展过程中。大量临床和实验资料表明 ,中医药在肝纤维化的防治中有着广阔的前景。自 1 995年 5月～ 1 997年 4月 ,我们采用病理组织学和血清学方法 ,应用抗纤方观察其对慢性乙型肝炎肝纤维化患者的疗效
Liver fibrosis is one of the pathological features of chronic liver disease and liver cirrhosis. This pathological change runs through the development of chronic liver disease. A large number of clinical and experimental data indicate that Chinese medicine has a broad prospect in the prevention and treatment of hepatic fibrosis. From May 1995 to April 1997, we used histopathology and serology to observe the effect of anti-fibroses on patients with chronic hepatitis B liver fibrosis.